Published in Transplantation on August 01, 1991
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol (1981) 4.75
20 years or more of follow-up of living kidney donors. Lancet (1992) 3.88
Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest (1992) 3.50
Limiting financial disincentives in live organ donation: a rational solution to the kidney shortage. Am J Transplant (2006) 3.31
The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med (1982) 3.13
Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients. Kidney Int (1999) 2.82
Pregnancy outcomes after kidney donation. Am J Transplant (2009) 2.66
Molecular basis of proteinuria of glomerular origin. N Engl J Med (1978) 2.61
Pancreatico-duodenal allotransplantation: experimental and clinical experience. Ann Surg (1970) 2.44
Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med (1982) 2.44
Organ donation in three major American cities with large Latino and black populations. Transplantation (1988) 2.41
The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients. Transplantation (1987) 2.40
Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int (1981) 2.36
Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med (1990) 2.32
Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest (1985) 2.32
Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation. Transplantation (2000) 2.25
Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res (1981) 2.25
Orthotopic liver transplantation: a pathological study of 63 serial liver biopsies from 17 patients with special reference to the diagnostic features and natural history of rejection. Hepatology (1985) 2.18
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery (1994) 2.13
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Transplantation of discordant xenografts: a review of progress. Immunol Today (1990) 2.00
Risk factors for chronic rejection in renal allograft recipients. Transplantation (1993) 1.90
Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg (2001) 1.89
Altered glomerular permselectivity and progressive sclerosis following extreme ablation of renal mass. Kidney Int (1982) 1.86
Cytomegalovirus-induced immune suppression. I. Humoral immunity. Clin Exp Immunol (1974) 1.86
Association of renal allograft rejection with virus infections. Am J Med (1974) 1.83
Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg (1996) 1.83
Increased incidence of malignancy during chronic renal failure. Lancet (1975) 1.79
Are wound complications after a kidney transplant more common with modern immunosuppression? Transplantation (2001) 1.73
Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet (1972) 1.71
Role of aldosterone in the remnant kidney model in the rat. J Clin Invest (1996) 1.65
Hepatocellular transplantation for metabolic deficiencies: decrease of plasms bilirubin in Gunn rats. Science (1976) 1.65
Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation (1995) 1.65
Long-term follow-up of living kidney donors: quality of life after donation. Transplantation (1999) 1.65
Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med (1988) 1.65
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
Hepatic resection for secondary neoplasms. Surgery (1982) 1.64
Complications and risks of living donor nephrectomy. Transplantation (1997) 1.61
The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation (1994) 1.58
Downloadable computer models for renal replacement therapy. Kidney Int (2006) 1.56
Cytomegalovirus-induced immune suppression. II. Cell-mediated immunity. Clin Exp Immunol (1974) 1.55
Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest (1984) 1.55
Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med (1990) 1.53
The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery (1981) 1.53
Colon perforation after renal transplantation: a single-institution review. Clin Transplant (1997) 1.47
Successful transplantation after conversion of a positive crossmatch to negative by dissociation of IgM antibody. Transplantation (1989) 1.46
Anatomical, electrophysiological and pigmentary aspects of vision in the bush baby: an interpretative study. Vision Res (1965) 1.46
Clinical characteristics of the lethal cytomegalovirus infection following renal transplantation. Surgery (1977) 1.45
Fractionated total lymphoid irradiation as preparative immunosuppression in high risk renal transplantation: clinical and immunological studies. Ann Surg (1982) 1.44
Selective retransplant after graft loss to nonadherence: success with a second chance. Am J Transplant (2009) 1.44
Circadian variation in the rejection of rat kidney allografts. Surgery (1973) 1.43
Steroid diabetes in renal transplant recipients: pathogenetic factors and prognosis. Surgery (1973) 1.43
A rapid method for purification of large quantities of anti-lymphocytic serum. Proc Soc Exp Biol Med (1967) 1.42
Intra-abdominal infections in pancreas transplant recipients. Ann Surg (1986) 1.42
Systemic fat embolism after renal homotransplantation and treatment with corticosteroids. N Engl J Med (1965) 1.42
2,500 living donor kidney transplants: a single-center experience. Ann Surg (2001) 1.41
Hyperglycemic nonketotic coma after liver transplantation. Arch Surg (1972) 1.40
First things first: laying the ethical and factual groundwork for living kidney donor selection standards. Am J Transplant (2008) 1.40
The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis. J Exp Med (1973) 1.40
Uremic pericardial effusion. Treatment by catheter drainage and local nonabsorbable steroid administration. Nephron (1976) 1.39
Severe flank pain as the predominant symptom of IgA nephropathy. Am J Kidney Dis (1989) 1.39
Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy. Surg Gynecol Obstet (1988) 1.38
Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Ann Surg (1969) 1.37
Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg (1995) 1.37
Cure of dysgerminoma with widespread metastases appearing after renal transplantation. N Engl J Med (1970) 1.36
Cyclosporin A in renal transplantation: a prospective randomized trial. Surgery (1982) 1.36
Glomerular basement membrane: in vitro studies of water and protein permeability. Am J Physiol (1992) 1.36
The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med (1989) 1.35
Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant (2013) 1.34
Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis. Ann Surg (1980) 1.34
Protection of the donor kidney during homotransplantation. Ann Surg (1966) 1.34
Cytomegalovirus: Clinical virological correlations in renal transplant recipients. Ann Surg (1974) 1.34
Synergistic effects on DNA synthesis of phytohemagglutinin or concanavalin A and lipopolysaccharide in human peripheral blood lymphocytes. J Immunol (1975) 1.32
Liver allograft rejection. An analysis of the use of biopsy in determining outcome of rejection. Am J Surg Pathol (1987) 1.30
Human islet autotransplantation following pancreatectomy. Transplant Proc (1979) 1.30
Prevention of end-stage renal disease due to type 2 diabetes. N Engl J Med (2001) 1.30
Prevention of urological complications after kidney transplantation. Ann Surg (1971) 1.29
Pancreatic islet cell transplantation. Surg Clin North Am (1978) 1.28
Renal transplantation in high-risk patients. Arch Surg (1971) 1.28
An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation (1996) 1.27
Transplantation of pediatric donor kidneys to adult recipients. Is there a critical donor age? Ann Surg (1986) 1.26
The course of the remnant kidney model in mice. Kidney Int (1999) 1.26
Seven years' experience with antilymphoblast globulin for renal transplantation from cadaver donors. Ann Surg (1976) 1.26
Renal transplantation in children ages 1 to 5 years. Pediatrics (1978) 1.25
Glomerular permselectivity: barrier function based on discrimination of molecular size and charge. Am J Physiol (1978) 1.25